Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Familial Dyslipidemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03110432
What this trial is testing

Prospective German Very High Cardiovascular Risk Patients Dyslipidemia Treatment Indication Registry

Who this might be right for
DyslipoproteinemiasHypercholesterolemia, FamilialFamilial Hypercholesterolemia - Homozygous+1 more
GWT-TUD GmbH 1,695
Large-scale testing (Phase 3)Study completedNCT00891306
What this trial is testing

Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient Subjects

Who this might be right for
Familial Lipoprotein Lipase Deficiency
Amsterdam Molecular Therapeutics 5
Early research (Phase 1)Study completedNCT03747224
What this trial is testing

Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients

Who this might be right for
DyslipidemiasFamilial HypercholesterolemiaHypertriglyceridemia
Arrowhead Pharmaceuticals 93
Testing effectiveness (Phase 2)Study completedNCT01146522
What this trial is testing

Safety, Tolerability,Pharmacokinetics(PK)and Pharmacodynamics(PD)Assessment of LCQ908 in Patients With Severe Hypertriglyceridemia

Who this might be right for
Hyperlipoproteinemia
Novartis Pharmaceuticals 8
Testing effectiveness (Phase 2)Study completedNCT00280995
What this trial is testing

Dose-escalating Safety Study of ISIS 301012 in Homozygous Familial Hypercholesterolemia Subjects on Lipid Lowering Therapy

Who this might be right for
Hypercholesterolemia, Familial
Kastle Therapeutics, LLC 12
Post-approval studies (Phase 4)Study completedNCT00754039
What this trial is testing

Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol

Who this might be right for
HypercholesterolemiaHyperlipidemia, Familial Combined
Daiichi Sankyo 129
Not applicableStudy completedNCT05218005
What this trial is testing

Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia

Who this might be right for
Familial HypercholesterolemiaFamilial Hypercholesterolemia Due to Genetic Defect of Apolipoprotein BFamilial Hypercholesterolemia Due to Heterozygous LDL Receptor Mutation+5 more
University of British Columbia 140
Very early researchStudy completedNCT00465751
What this trial is testing

Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism

Who this might be right for
Metabolic SyndromeFamilial HypertriglyceridemiaFamilial Combined Hyperlipidemia
University Hospital, Basel, Switzerland 30
Not applicableUnknownNCT05638022
What this trial is testing

Pilot Project of Familial Hypercholesterolemia Screening in Newborns in the Czech Republic

Who this might be right for
Familial Hypercholesterolaemia
Institute of Health Information and Statistics of the Czech Republic 10,000
Post-approval studies (Phase 4)Study completedNCT06231459
What this trial is testing

Expression of Pro- and Anti-inflammatory Cytokines During Anti-PCSK9 in Familial Hypercholesterolemia

Who this might be right for
Hypercholesterolemia, Familial
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado 20
Testing effectiveness (Phase 2)Ended earlyNCT01675154
What this trial is testing

Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 Hyperlipoproteinemia

Who this might be right for
Type 1 Hyperlipoproteinemia
University of Texas Southwestern Medical Center 5
Testing effectiveness (Phase 2)Ended earlyNCT02651675
What this trial is testing

A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)

Who this might be right for
Homozygous Familial Hypercholesterolemia (HoFH)
REGENXBIO Inc. 9
Not applicableStudy completedNCT02286596
What this trial is testing

Comparisons of Two Low-density Lipoprotein Apheresis Systems in Patients With Homozygous Familial Hypercholesterolemia

Who this might be right for
Homozygous Familial Hypercholesterolemia
Laval University 9
Not applicableUnknownNCT01960244
What this trial is testing

Study of Awareness and Detection of Familial Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
The Familial Hypercholesterolemia Foundation 5,000
Not applicableEnrolling By InvitationNCT04929457
What this trial is testing

Evaluation of a Digiphysical Screening Method to Identify and Diagnose Familial Hypercholesterolemia

Who this might be right for
Familial HypercholesterolemiaHypercholesterolemia
Karolinska Institutet 30,000
Large-scale testing (Phase 3)Study completedNCT00171236
What this trial is testing

Efficacy and Safety of Fluvastatin in Children With Heterozygous Familial Hypercholesterolemia

Who this might be right for
Heterozygous Familial HypercholesterolemiaMixed Dyslipidemia
Novartis 84
Testing effectiveness (Phase 2)Looking for participantsNCT07489209
What this trial is testing

A Dose-exploration Study of EDP167 in HoFH

Who this might be right for
Homozygous Familial Hypercholesterolemia (HoFH)
Eddingpharm (Zhuhai) Co., Ltd. 20
Large-scale testing (Phase 3)Study completedNCT01623115
What this trial is testing

Efficacy and Safety of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in Patients With Heterozygous Familial Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy

Who this might be right for
Hypercholesterolemia
Sanofi 486
Large-scale testing (Phase 3)Study completedNCT00706849
What this trial is testing

Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease

Who this might be right for
Heterozygous Familial HypercholesterolemiaCoronary Artery Disease
Kastle Therapeutics, LLC 124
Testing effectiveness (Phase 2)Study completedNCT02048410
What this trial is testing

Efficacy of a New Symbiotic Formulation in Children With Familial Hypercholesterolemia

Who this might be right for
DyslipidemiaFamilial Hypercholesterolemia
Federico II University 40
Next Page